Pulse NanoMED for AIS

About Euphrates Vascular

Euphrates Vascular is pioneering a novel nanotechnology-based platform to address a critical unmet need in interventional medicine: distal vessel occlusions. Its core technology, the Pulse NanoMED™ System, utilizes magnetically guided iron-oxide nanoparticles to disrupt clots and potentially enhance drug delivery in hard-to-reach vasculature. The company is targeting three major cardiovascular indications—stroke, heart attack, and limb ischemia—where achieving complete tissue reperfusion remains a significant clinical challenge. As a pre-revenue, pre-clinical stage venture, its success hinges on translating its disruptive concept into a clinically validated and commercially viable medical device.

Therapeutic Areas

Other Acute Ischemic Stroke Drugs